Phase 2 mCRPC (Metastatic Castration-resistant Prostate Cancer) trials recruiting now

All mCRPC (Metastatic Castration-resistant Prostate Cancer) trials, every phase

Other phases for mCRPC (Metastatic Castration-resistant Prostate Cancer)

Phase 2 mCRPC (Metastatic Castration-resistant Prostate Cancer) trials

• A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
  NCT06785636 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 19 locations
• A Study of MHB048C in Patients With Advanced Solid Tumors
  NCT07192120 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
  NCT06844383 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 8 locations
• Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer
  NCT06190899 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 13 locations
• SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC
  NCT07451795 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: Male · 3 locations
• Study of XNW5004 Tablet in Combination With Enzalutamide in Subjects With Metastatic Castration-Resistant Prostate Cancer
  NCT06702995 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 2 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.